114 related articles for article (PubMed ID: 9356148)
1. Nonspecific amine immobilization of ligand can Be a potential source of error in BIAcore binding experiments and may reduce binding affinities.
Kortt AA; Oddie GW; Iliades P; Gruen LC; Hudson PJ
Anal Biochem; 1997 Nov; 253(1):103-11. PubMed ID: 9356148
[TBL] [Abstract][Full Text] [Related]
2. Single-chain Fv of anti-idiotype 11-1G10 antibody interacts with antibody NC41 single-chain Fv with a higher affinity than the affinity for the interaction of the parent Fab fragments.
Iliades P; Dougan DA; Oddie GW; Metzger DW; Hudson PJ; Kortt AA
J Protein Chem; 1998 Apr; 17(3):245-54. PubMed ID: 9588948
[TBL] [Abstract][Full Text] [Related]
3. Influence of mass transfer and surface ligand heterogeneity on quantitative BIAcore binding data. Analysis of the interaction of NC10 Fab with an anti-idiotype Fab'.
Kortt AA; Gruen LC; Oddie GW
J Mol Recognit; 1997; 10(3):148-58. PubMed ID: 9408831
[TBL] [Abstract][Full Text] [Related]
4. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.
Kortt AA; Nice E; Gruen LC
Anal Biochem; 1999 Aug; 273(1):133-41. PubMed ID: 10452809
[TBL] [Abstract][Full Text] [Related]
6. Identification and minimization of nonideal binding effects in BIAcore analysis: ferritin/anti-ferritin Fab' interaction as a model system.
Oddie GW; Gruen LC; Odgers GA; King LG; Kortt AA
Anal Biochem; 1997 Jan; 244(2):301-11. PubMed ID: 9025947
[TBL] [Abstract][Full Text] [Related]
7. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
Nuss JM; Whitaker PB; Air GM
Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
[TBL] [Abstract][Full Text] [Related]
8. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
9. Defining the requirements for an antibody epitope on influenza virus neuraminidase: how tolerant are protein epitopes?
Nuss JM; Air GM
J Mol Biol; 1994 Jan; 235(2):747-59. PubMed ID: 7507170
[TBL] [Abstract][Full Text] [Related]
10. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
Schlapschy M; Gruber H; Gresch O; Schäfer C; Renner C; Pfreundschuh M; Skerra A
Protein Eng Des Sel; 2004 Dec; 17(12):847-60. PubMed ID: 15708864
[TBL] [Abstract][Full Text] [Related]
11. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
Tulip WR; Varghese JN; Laver WG; Webster RG; Colman PM
J Mol Biol; 1992 Sep; 227(1):122-48. PubMed ID: 1381757
[TBL] [Abstract][Full Text] [Related]
12. [Optimization of methods of immobilization of anti-immunoglobulins. Equilibrium parameters of the interaction of immobilized antibodies with an antigen].
Guzov VM; Rodionov MA; Golubovich VP; But'kova LS; Chashchin VL
Biokhimiia; 1988 Feb; 53(2):238-50. PubMed ID: 3285896
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of the effect on Fab binding of identical substitutions in a peptide and its parent protein.
Choulier L; Rauffer-Bruyère N; Ben Khalifa M; Martin F; Vernet T; Altschuh D
Biochemistry; 1999 Mar; 38(12):3530-7. PubMed ID: 10090739
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
16. Characterization and binding of intracellular antibody fragments to the hepatitis C virus core protein.
Heintges T; zu Putlitz J; Wands JR
Biochem Biophys Res Commun; 1999 Sep; 263(2):410-8. PubMed ID: 10491307
[TBL] [Abstract][Full Text] [Related]
17. Antibody multispecificity mediated by conformational diversity.
James LC; Roversi P; Tawfik DS
Science; 2003 Feb; 299(5611):1362-7. PubMed ID: 12610298
[TBL] [Abstract][Full Text] [Related]
18. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
19. The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody.
Malby RL; Tulip WR; Harley VR; McKimm-Breschkin JL; Laver WG; Webster RG; Colman PM
Structure; 1994 Aug; 2(8):733-46. PubMed ID: 7994573
[TBL] [Abstract][Full Text] [Related]
20. Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer.
Kortt AA; Lah M; Oddie GW; Gruen CL; Burns JE; Pearce LA; Atwell JL; McCoy AJ; Howlett GJ; Metzger DW; Webster RG; Hudson PJ
Protein Eng; 1997 Apr; 10(4):423-33. PubMed ID: 9194168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
